E. Hamel et al., 5-HT(1) RECEPTORS MEDIATING CONTRACTION IN BOVINE CEREBRAL-ARTERIES -A MODEL FOR HUMAN CEREBROVASCULAR 5-HT(1D-BETA) RECEPTORS, European journal of pharmacology, 242(1), 1993, pp. 75-82
We report on the pharmacological profile of the 5-HT receptor which in
duces contraction of the bovine isolated cerebral arteries. Several 5-
HT receptor agonists were tested for their ability to induce vasoconst
riction in bovine pial arteries and their potencies were compared to t
hat of 5-HT. The rank order of agonist potency can be summarized as 5-
carboxamidotryptamine (5-CT) = RU 24969 greater-than-or-equal-to 5-HT
> sumatriptan > alpha-methyl-5-HT > methysergide > 2-methyl-5-HT > rop
ylamino-8-hydroxy-1,2,3,4-tetrahydronaphthalene (8-OH-DPAT). Only meth
ysergide induced a-contraction which was smaller than that elicited by
5-HT. Antagonists with selective affinity at 5-HT1A/1B (propranolol),
5-HT1C (mesulergine), 5-HT2 (ketanserin, mianserin) and 5-HT3 (MDL 72
222) sites were inactive to block the 5-HT-induced contraction. In con
trast, the 5-HT1/5-HT2 receptor antagonists methiothepin and metergoli
ne inhibited the 5-HT-induced response with relatively high affinity (
pA2 = 8.16 +/- 0.26 and 6.73 +/- 0.05, respectively). Overall, this ph
armacological profile indicated clearly that a 5-HT1 receptor, most cl
osely related to the 5-HT1D subtype, is responsible for the 5-HT-induc
ed contraction of bovine cerebral arteries. Correlation analysis of th
e potencies of a series of 5-HT receptor agonists and antagonists in b
ovine and human cerebrovascular preparations showed a highly significa
nt positive correlation (r = 0.94, P = 0.005 1). Analyses of the corre
lation between the agonist and antagonist potencies at bovine cerebrov
ascular receptors and their published affinities at the cloned human 5
-HT1Dalpha and 5-HT1Dbeta (or human 5-HT1B) receptors showed a highly
significant correlation only with the 5-HT1Dbeta (r = 0.82; P = 0.006)
subtype. We conclude that cerebral vasoconstriction in bovine cerebra
l arteries is mediated by a receptor homologous to the human cerebrova
scular 5-HT1D receptor and that bovine pial arteries appear to be the
best available pharmacological model for the human cerebrovascular 5-H
T1D receptor. Further, the results suggest that bovine cerebrovascular
5-HT1D receptors resemble the cloned human 5-HT1Dbeta (or human 5-HT1
B) receptor subtype.